Speaker illustration

Doctor Evmorfia Aivalioti

National & Kapodistrian University of Athens Medical School, Athens (Greece)

Member of:

European Society of Cardiology

Amyloid beta, a marker of vascular aging and cardiovascular disease, is associated with accelerated progression of renal dysfunction

Event: ESC Congress 2024

Topic: Epidemiology

Session: Secondary prevention: a multifactorial approach

Thumbnail

Circulating Amyloid beta 1-40 is independently associated with statin treatment and LDL cholesterol reduction: a prospective cohort study

Event: ESC Congress 2024

Topic: Lipids

Session: Lipoproteins and cardiovascular risk

Thumbnail

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Event: ESC Congress 2024

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session: Liver metabolism and heart disease

Thumbnail